Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trialRalf‐Dieter Hofheinz, Andreas Hochhaus, Stefan Post et al.|The Lancet Oncology|2012Cited by 505
Clinical responses to PD-1 inhibition and their molecular characterization in six patients with mismatch repair-deficient metastatic cancer of the digestive systemDaniela Hirsch, Deniz Gencer|Journal of Cancer Research and Clinical Oncology|2020Cited by 9